SCHEMBL22978799

SCHEMBL22978799

CCC1CCCCN1C(=O)OS(=O)(=O)c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.62
RAB9A P51151 3/20 0.62
HPGD P15428 3/20 0.53
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
DAGLA Q9Y4D2 3/20 0.48
ATM Q13315 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
ABHD11 Q8NFV4 1/20 0.48
MAPT P10636 1/20 0.48
HTT P42858 1/20 0.47
ALDH1A1 P00352 4/20 0.46
LMNA P02545 1/20 0.46
KDM4E B2RXH2 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
TSHR P16473 1/20 0.45
POLB P06746 1/20 0.44
TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14646609 0.77 NPC1 (0.60) NPC1RAB9AHPGDMEN1KMT2A
SCHEMBL13198885 0.77 NPC1 (0.60) NPC1RAB9AHPGDMEN1KMT2A
SCHEMBL5697162 0.75 ALDH1A1 (0.63) NPC1RAB9AHPGDMEN1KMT2A
SCHEMBL31106406 0.74 NPC1 (0.60) NPC1RAB9AHPGDMEN1KMT2A
SCHEMBL7918528 0.73 HCRTR2 (0.49) NPC1RAB9AMEN1KMT2A
SCHEMBL7918530 0.73 HCRTR2 (0.49) NPC1RAB9AMEN1KMT2A
SCHEMBL809534 0.73 PREP (0.57) NPC1RAB9AMEN1KMT2AATM
SCHEMBL14578664 0.72 HPGD (0.76) NPC1RAB9AHPGDMEN1KMT2A
SCHEMBL13198897 0.72 KMT2A (0.51) NPC1RAB9AHPGDMEN1KMT2A
SCHEMBL21057416 0.72 KDM4E (0.52) NPC1RAB9AHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021026803-A1 PIPERIDINYL-METHYL-PURINEAMINES AS NSD2 INHIBITORS AND ANTI-CANCER AGENTS NOVARTIS AG (CH) 2021-02-18 WO disclosed